Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume – Time to Buy?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw unusually-high trading volume on Friday. Approximately 4,600 shares changed hands during mid-day trading, an increase of 602% from the average daily volume of 655 shares. The stock last traded at $13.30 and had previously closed at $13.00.

Wall Street Analysts Forecast Growth

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One analyst has rated the stock with a Hold rating. According to MarketBeat.com, Ambu A/S currently has a consensus rating of “Hold”.

Ambu A/S Stock Performance

The company has a market cap of $3.13 billion, a P/E ratio of 35.95 and a beta of 0.86. The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08. The company has a 50 day moving average price of $11.31 and a 200-day moving average price of $10.97.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.14 earnings per share for the quarter. Ambu A/S had a net margin of 9.90% and a return on equity of 10.47%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical-device company that develops, manufactures and markets equipment for hospitals and other healthcare settings. Its products are used in anesthesia, patient monitoring and diagnostics, and endoscopy. The company’s portfolio includes ventilation and resuscitation devices, electrodes and single-use endoscopes. Ambu is also known for the Ambu bag, a self-inflating resuscitation bag introduced in the 1950s. Founded in Denmark in 1937, Ambu serves healthcare professionals in markets around the world.